Skip to main content
TipRanks
Go Ultimate75% OFF

Sanjeev Pandya Insider Profile

4 Followers

Sanjeev Pandya, Director at ImmuPharma, holds 125.00K shares in ImmuPharma (Ticker: GB:IMM), holds 58.62K shares in Advanced Oncotherapy (Ticker: GB:AVO). Most recently, Sanjeev Pandya Bought ― shares of ImmuPharma on Aug 24, 2021 for an estimated value of 10.00K .

Sanjeev Pandya's Trading History

IMM
ImmuPharma
Aug 24, 2021DirectorInformative Buy10.00K£3.52K
AVO
Advanced Oncotherapy
Nov 08, 2016―Informative Buy35.00K£1.03K

You May Also Like

Sanjeev Pandya insider profile FAQ

What is the percentage of profitable transactions made by Sanjeev Pandya?
The percentage of profitable transactions made by Sanjeev Pandya is 25%.
What is the average return per transaction made by Sanjeev Pandya?
The average return per transaction made by Sanjeev Pandya is 74.80%.
What stocks does Sanjeev Pandya hold?
Sanjeev Pandya holds: GB:IMM, GB:AVO stocks.
What was Sanjeev Pandya’s latest transaction?
Sanjeev Pandya’s latest transaction was an Informative Buy of 10.00K .
What was Sanjeev Pandya's most profitable transaction?
Sanjeev Pandya’s most profitable transaction was an Informative Buy of GB:AVO stock on April 17, 2014. The return on the trade was 418.10%.
What is Sanjeev Pandya's role in ImmuPharma?
Sanjeev Pandya's role in ImmuPharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.